BEUDAMED
    9 results · 24ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Pre Market Approval ×

    Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

    FDA Pre-Market Approval
    FDA Class 3 ·GENESEARCH BREAST LYMPH NODE (BLN) ASSAY

    Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

    FDA Pre-Market Approval
    FDA Class 3 ·GENESEARCH BREAST LYMPH NODE

    Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

    FDA Pre-Market Approval
    FDA Class 3 ·GENESEARCH BREAST LYMPH NODE ASSAY

    Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

    FDA Pre-Market Approval
    FDA Class 3 ·GENESEARCH BREAST LYMPH NODE(BLN) ASSAY

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST

    Dna-Probe, B And T Lymphocyte

    FDA Pre-Market Approval
    FDA Class 2 ·ONCOR B/T GENE REARRANGEMENT TEST